Comments

Voyager Therapeutics

Q: What sector and industry does Voyager Therapeutics (VYGR) operate in?

Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VYGRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.83

-0.0100-0.15%

At close: -

$6.83

00.00%

After Hours: 4:00 PM EDT

15 minutes delayed

Voyager Therapeutics (VYGR) Forecast

News Earnings Voyager Therapeutics (VYGR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Voyager Therapeutics (NASDAQ:VYGR) Stock Quotes, Forecast and News Summary

Voyager Therapeutics Stock (NASDAQ: VYGR) stock price, news, charts, stock research, profile.

Open	$6.83
Close	$6.83
Volume / Avg.	683.02K / 513.90K
Day Range	$6.61 - $6.95
52 Wk Range	5.71 - 11.72
Market Cap	$372.46M
P/E Ratio	25.37
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	7.54%
Days to Cover	6.04

Recent News

Puma Biotechnology's Q1 Earnings and Revenues Beat

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Zacks

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term value.

Vandana Singh

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jul

Aug

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.83
Close	$6.83
Volume / Avg.	683.02K / 513.90K
Day Range	$6.61 - $6.95
52 Wk Range	5.71 - 11.72
Market Cap	$372.46M
P/E Ratio	25.37
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	7.54%
Days to Cover	6.04

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Voyager Therapeutics (VYGR) stock?

You can purchase shares of Voyager Therapeutics (NASDAQ:VYGR) through any online brokerage.

View our list of the best stock brokerages

Who are Voyager Therapeutics (VYGR) competitors?

Other companies in Voyager Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), 4D Molecular Therapeutics (NASDAQ:FDMT), Inozyme Pharma (NASDAQ:INZY), Sage Therapeutics (NASDAQ:SAGE) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the forecast, or price target, for Voyager Therapeutics (VYGR) stock?

Voyager Therapeutics has a consensus price target of $15.80.

What is the current price for Voyager Therapeutics (VYGR)?

The stock price for Voyager Therapeutics (NASDAQ: VYGR) is $6.83 last updated October 31, 2024 at 4:00 PM EDT.

Does Voyager Therapeutics (VYGR) pay a dividend?

There are no upcoming dividends for Voyager Therapeutics.

When is Voyager Therapeutics (NASDAQ:VYGR) reporting earnings?

Voyager Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Voyager Therapeutics (VYGR) going to split?

There is no upcoming split for Voyager Therapeutics.

What sector and industry does Voyager Therapeutics (VYGR) operate in?

Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.